Donate
|
Resource Hub
Who we are
Our Strategy
Strategy Extension
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Where We Work
Poliovirus
Wild Poliovirus
Variant Poliovirus (cVDPV)
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Surveillance
Supplementary Immunization
Outbreak Preparedness & Response
Containment
Routine Immunization
Gender Mainstreaming
Polio Gender Champions
Integration
Environmental Safeguarding
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Financing
Financial Resource Requirements
GPEI Budget 2024
GPEI Budget 2023
GPEI Budget 2022
2020-2024 outbreak budget monitoring
Donors
Expenditure Information
News
Media Centre
Take Action
Who we are
Our Strategy
Strategy Extension
Post-Polio World
OPV Cessation
Polio Post-Certification Strategy
Transition Planning
Our Partners
Governance
Advisory and Policy Groups
International Health Regulations Emergency Committee on international spread of poliovirus
Strategic Advisory Group of Experts on Immunization
Global Commission for the Certification of Eradication of Poliomyelitis
Independent Monitoring Board
Transition Independent Monitoring Board
About Polio
Polio this week
Wild Poliovirus count
Vaccine Derived Poliovirus count
Where We Work
Poliovirus
Wild Poliovirus
Variant Poliovirus (cVDPV)
The Vaccines
Oral polio vaccine
Inactivated poliovirus vaccine
History of Polio
What we do
Surveillance
Supplementary Immunization
Outbreak Preparedness & Response
Containment
Routine Immunization
Gender Mainstreaming
Polio Gender Champions
Integration
Environmental Safeguarding
Research
Antivirals
Clinical Trials and Seroprevalence Surveys
Polio Research Committee
Grants and Collaborations
Financing
Financial Resource Requirements
GPEI Budget 2024
GPEI Budget 2023
GPEI Budget 2022
2020-2024 outbreak budget monitoring
Donors
Expenditure Information
News
Media Centre
Take Action
Choose the resource category and filter for results
Resources for Polio Eradicators
Containment
- Global Action Plan for Poliovirus Containment (GAP)
- Containment Certification Scheme (CCS)
- Potentially Infectious Material (PIM) guidance
- Exposure guidance
GPEI Tools, Protocols and Guidelines
- Polio Post-Certification Strategy
- Outbreak preparedness and response
- Vaccines and logistics
- Surveillance
- Supplementary Immunization Activities (SIA)
- Webinars and E-Learning
- Communication for Eradication Strategies
- Strategies
Policy & Reports
Advisory Committee on Poliomyelitis Eradication
AFRO Reports
Annual Reports
Containment Advisory Group
Declarations and Resolutions
Expenditure Reports
Financial Reports
- Non-FRR Reports
GACVS sub-committee on novel OPV2 safety
Gender Mainstreaming
Global Certification Commission
Global Polio Laboratory Network Reports
IMB Reports
Polio and Climate Change
Polio Newsletter
Polio Oversight Board (POB) Documents
Polio Oversight Board (POB) Letters
Polio Oversight Board (POB) Meeting Minutes
Polio Partners Group
Regional Certification Commission
Reports to WHO Governing Bodies
Semi-Annual Status Reports
Technical Advisory Groups
TIMB Reports
WHO Weekly Epidemiological Record
Multimedia
Photos
Videos
Sort by
Newest First
Oldest First
Filter
Reset
Resource Hub
150th Executive Board – 2022 | Polio transition planning and post-certification
spanish
|
russian
|
french
|
english
|
chinese
|
arabic
|
Reducing risk of Poliomeylitis outbreaks in emergencies – 2021 Interim
spanish
|
russian
|
french
|
english
|
PERFORMANCE OF ACUTE FLACCID PARALYSIS (AFP) | 26 November 2021, vol.96, no.47 (578-582)
20th Consultation with OPV/IPV Manufacturers, National Authorities for Containment, and National Regulatory Authorities, 12–13 October 2021, virtual
Progress towards poliomyelitis eradication | 08 October 2021, vol.96, no.40 (485-491)
PERFORMANCE OF ACUTE FLACCID PARALYSIS (AFP) | 01 October 2021, vol.96, no.39 (481-484)
Progress towards polio eradication | 27 August 2021, vol.96, no.34 (393-400)
Global Advisory Committee on Vaccine Safety sub-committee on novel OPV2 safety, 3 August 2021 – meeting summary
21st meeting of the Global Commission for the Certification of Eradication of Poliomyelitis, virtual 28 July 2021
Report of the Meeting of the WHO Global Advisory Committee | 23 July 2021, vol.96, no.29 (326-327)
Historical Contributions, 1988-2020
tOPV request form (for tOPV with a VVM on the label)
spanish
|
english
|
Polio Oversight Board | Letters 2021
June
|
September
|
December
|
20th Report – June 2021
Gender and Polio profile
english
|
french
|
1
…
9
10
11
12
13
…
42
